
CAS Arbitrator Denies U.S. Triathlon Athlete Andrew Starykowicz’s Appeal Against Therapeutic Use Exemption Decision
[…] USADA’s independent TUE Committee (TUEC) to deny his request for a Therapeutic Use Exemption (TUE). Starykowicz, 38, applied to USADA for a TUE for the beta-2 agonist vilanterol, prohibited at all times, on October 15, 2019. While his TUE application was pending, Starykowicz competed in an IRONMAN® triathlon in Panama City, Florida on November […]